Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: TokyoMex who wrote (952)	7/23/1998 12:19:00 AM
From: aknahow	Read Replies (1) \| Respond to of 1580

Thanks, nice informative post. I believe the recent bad news will indeed speed up Merck's interest in doing deals. While they have said they are not interested in acquisitions this also may change. Any insights on the types of biotech partnerships they might look at?

To: TokyoMex who wrote (952)	7/23/1998 7:21:00 AM
From: John Carragher	Read Replies (1) \| Respond to of 1580

I believe your reasoning is sound esp since mrk guided analysts in the future earnings. I sold some a few weeks ago and another 400 shares yesterday at the opening. Bought wla and lly. I still hold a good portion in mrk as a balance in my portfolio.. May I ask which companies you do prefer? thanks John

To: TokyoMex who wrote (952)	7/23/1998 7:33:00 AM
From: Rob L.	Read Replies (2) \| Respond to of 1580

I think the last sentence of this voluminous post says it all. Long term, this company is a great buy. This guy was probably telling people to sell when the health care fiasco kicked in several years ago. I bought then and I have continued to buy and it has rewarded me handsomely. Too much short term thinking in that post. Merck is and has always been the kind of stock that you, buy, hold and sell when you want to put your kids through college. It's a world class company with world class management and those that buy and hold will be rewarded (IMO) in time. The selling that is occurring right now is just profit taking. They missed the estimate due to foreign exchange fluctuations, nothing more. Market used it as an excuse to take profits (IMO). Look at Merck's performance over the past year, can't complain about that! In addition, MRK has periods where it pulls back and pulls back sharply. Consider it a good entry point.

To: TokyoMex who wrote (952)	7/23/1998 11:10:00 AM
From: aknahow	Read Replies (1) \| Respond to of 1580

You probably have seen todays article by JJCramer on TSC at thestreet.com Wrong! Rear Echelon Revelations: Cramer Dissects Merck's Drop By James J. Cramer 7/23/98 7:32 AM ET Let's step back for a second from the battleground, and remember what causes a stock to go down. You old-timers stop yawning. Everybody forgets this stuff all of the time, anyway. It's time for a complicated explanation to simple price movements. The stock in question is Merck (MRK:NYSE). Here is a company that has lost billions in shareholder value in two days. Was that wrong? Can we make some sense of it? TSC is a great buy at less than $70 per year for daily insights of value. Free trial available.